Pharmacokinetics and Pharmacodynamics
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
“Pharmacokinetics and Pharmacodynamics” is a Section of the peer-reviewed open access journal Pharmaceutics, which is devoted to highlighting the importance of pharmacokinetics and pharmacodynamics in drug development for better understanding of drug action. The Section welcomes original research articles as well as review papers that address a variety of related topics to novel and significant scientific findings by in vitro, in vivo, and clinical studies. The manuscript mainly focused on descriptive pharmacokinetics lacking novelty and scientific significance will not be considered for review.
Covered topics include:
- Mechanisms and factors affecting drug absorption, distribution, metabolism, and excretion;
- Kinetics of drug disposition and therapeutic effects;
- Pharmacokinetics, pharmacodynamics, and pharmacometrics;
- Toxicokinetics and toxicodynamics;
- Mathematical model for the assessment of drug ADME;
- Model-based drug development;
- Translational mathematical modeling in drug development;
- Quantitative systems pharmacology.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Effects of Obesity on Pharmacokinetics (Deadline: 31 August 2025)
- Advanced Algorithms for Small-Molecule Therapeutics Development (Deadline: 31 August 2025)
- Optimizing Pharmacokinetics Through Formulation Science and Technology (Deadline: 20 September 2025)
- Development of Physiologically Based Pharmacokinetic (PBPK) Modeling (Deadline: 30 September 2025)
- Optimizing Drug Therapy in Kidney Diseases: Effectiveness and Safety (Deadline: 30 September 2025)
- Advancing Biologic Drug Development Through Physiologically Based Pharmacokinetic Modelling and Simulations (Deadline: 30 September 2025)
- Challenges and Trends in Geriatric Pharmacotherapy: Pharmacodynamics, Pharmacokinetics, and Personalized Therapeutic Strategies (Deadline: 30 September 2025)
- In Silico Pharmacokinetic and Pharmacodynamic (PK-PD) Modeling (Deadline: 30 September 2025)
- Drug–Drug Interactions—New Perspectives (Deadline: 30 October 2025)
- Advances in Anticancer Drug Metabolism Research: Implications for Personalized Therapeutics (Deadline: 31 October 2025)
- Metal Complexes as Antimicrobial Agents: Pharmacokinetics and Drug Development Implications (Deadline: 31 October 2025)
- Advancing HIV Prevention and Treatment: Pharmacokinetics, Pharmacodynamics, Toxicokinetics, Formulation and Delivery of Antiretroviral Drugs (Deadline: 31 October 2025)
- Innovations in Drug Delivery, Pharmacometrics, and Clinical Studies in Veterinary Medicine (Deadline: 31 October 2025)
- Advanced In Silico Methods and Digital Platforms for the Prediction of ADMET and Pharmacokinetics Properties (Deadline: 31 October 2025)
- Pathophysiological Influences on Pharmacokinetics and Pharmacodynamics (Deadline: 20 November 2025)
- Recent Advances in Physiologically Based Biopharmaceutics Modeling (Deadline: 30 November 2025)
- Recent Advances in Physiologically Based Pharmacokinetics (Deadline: 31 December 2025)
- Model-Informed Precision Dosing in Drug Development and Clinical Practice (Deadline: 31 December 2025)
- The Integration of Novel Approaches in Laboratory Medicine into Precision Pharmacotherapy (Deadline: 31 December 2025)
- Advances in Pharmacokinetics of Targeted Anti-Cancer Drugs (Deadline: 20 January 2026)
- Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling and Applications (Deadline: 31 January 2026)
- Model Informed Precision Dosing in Special Populations: Bridging Physiology, Models and Clinical Practice (Deadline: 28 February 2026)
- Population Pharmacokinetics and Its Clinical Applications (Deadline: 28 February 2026)
- Mechanism-Based Pharmacokinetic and Pharmacodynamic Modeling (Deadline: 20 April 2026)
- Advances in Pharmacokinetics and Drug Interactions (Deadline: 20 April 2026)
- Personalizing Drug Therapy: The Role of Pharmacokinetics and Therapeutic Drug Monitoring (Deadline: 30 April 2026)
